Generative AI: Powering the next era of life sciences innovations
Generative AI in life sciences landscape is poised to drive innovation, offering solutions for drug discovery, clinical trials, and manufacturing processes.
Dimension raises $500M second fund for investing at the intersection tech and life sciences | TechCrunch
Dimension Capital successfully raised a $500 million fund in 2024, demonstrating strong investor confidence despite broader capital-raising challenges.
UK-based Exciting Instruments raises 4.7M in Seed funding
Exciting Instruments raised £4M to enhance single-molecule detection technology, aiming for broader access in research and clinical applications.
Generative AI: Powering the next era of life sciences innovations
Generative AI in life sciences landscape is poised to drive innovation, offering solutions for drug discovery, clinical trials, and manufacturing processes.
Dimension raises $500M second fund for investing at the intersection tech and life sciences | TechCrunch
Dimension Capital successfully raised a $500 million fund in 2024, demonstrating strong investor confidence despite broader capital-raising challenges.
UK-based Exciting Instruments raises 4.7M in Seed funding
Exciting Instruments raised £4M to enhance single-molecule detection technology, aiming for broader access in research and clinical applications.
'World-class' science hub bringing thousands of jobs moves step closer
The new development will add significant life sciences space and community amenities near Royal London Hospital, pending approval from the Mayor of London.
Work gets under way on Europe's biggest life sciences building in Canary Wharf
One North Quay, a significant development in London, will be a leading hub for life sciences and technology, fostering innovation and sustainability.
'World-class' science hub bringing thousands of jobs moves step closer
The new development will add significant life sciences space and community amenities near Royal London Hospital, pending approval from the Mayor of London.
Work gets under way on Europe's biggest life sciences building in Canary Wharf
One North Quay, a significant development in London, will be a leading hub for life sciences and technology, fostering innovation and sustainability.
UNIIQ invests 2.5M in these 7 startups - Silicon Canals
UNIIQ invests €2.5M in several deep tech and life sciences startups to bolster innovation and sustainability in the region.
AstraZeneca's 450 million vaccine plant at risk as government reconsiders financial backing
The Treasury is in talks with AstraZeneca regarding a £450 million vaccine facility, but funding support is significantly reduced, raising concerns about investment viability.
Sweden's SmiLe Inject Capital invests 800K in 3 startups
SmiLe Inject Capital invests in three life science startups to boost innovations in healthcare and support their commercial growth.
UNIIQ invests 2.5M in these 7 startups - Silicon Canals
UNIIQ invests €2.5M in several deep tech and life sciences startups to bolster innovation and sustainability in the region.
AstraZeneca's 450 million vaccine plant at risk as government reconsiders financial backing
The Treasury is in talks with AstraZeneca regarding a £450 million vaccine facility, but funding support is significantly reduced, raising concerns about investment viability.
Sweden's SmiLe Inject Capital invests 800K in 3 startups
SmiLe Inject Capital invests in three life science startups to boost innovations in healthcare and support their commercial growth.
Addgene streamlines the sharing of plasmids to facilitate research and collaboration in the life sciences.
A snapshot of Lithuania's life-sciences landscape
Lithuania aims to enhance research in life sciences and biotechnology by retaining local talent, attracting international researchers, and promoting collaboration over competition.
Twenty years of Addgene
Addgene streamlines the sharing of plasmids to facilitate research and collaboration in the life sciences.
A snapshot of Lithuania's life-sciences landscape
Lithuania aims to enhance research in life sciences and biotechnology by retaining local talent, attracting international researchers, and promoting collaboration over competition.
HP secures up to $50 million in CHIPS Act funding to expand an Oregon facility
HP receives $50 million from the CHIPS Act to modernize its Oregon plant, aiming to create over 250 jobs and support innovations in life sciences.
Boston ranks No. 19 of top 20 metros for new apartment construction
Boston will see 1,813 new apartment units in 2024, driven by demand from the life science sector.
"Life does not exist": The deceptively tricky task of defining life
Life is fundamentally challenging to define, blurring the lines between living and non-living.
Prominent scientists argue about the essence and existence of life, suggesting it may be an illusion.
Stockbridge set to start medical office building in Beverly Grove
Stockdale Capital Partners is developing a 12-story medical office and life sciences building in Beverly Grove, set to replace a Big 5 Sporting Goods store, with construction starting in December 2022.
Metabolon Secures $60M Credit Facility to Accelerate Growth Initiatives
Metabolon secured $60M credit facility from Trinity Capital, enabling growth in R&D, global expansion for metabolomics solutions in life sciences.
Via Scientific Secures $5 Million in Seed Funding Led by G20 Ventures and Innospark Ventures
Via Scientific, developer of Via Foundry, raised $5 million in seed funding to accelerate the pace of life sciences discovery.
The Via Foundry platform provides a comprehensive multi-omics solution for analyzing data across various disciplines and leveraging AI to identify patterns and biomarkers.
Generative AI: The new era of life sciences innovation
AWS's generative AI solutions provide transformative opportunities for life sciences organizations. Accelerate drug discovery, streamline manufacturing oversight, enhance patient engagement, access foundation models, manage data securely, and scale AI workloads on AWS high-performance infrastructure.